Secondary outcomes | MP group (n = 25) | DXM group (n = 25) | p-value |
---|---|---|---|
Day 5 PaO2/FiO2ratio; mean ± S.D. | 355.6 ± 79.1 | 338.9 ± 82.9 | 0.474 |
Hypoxemia PaO2/FiO2 ratio > 300 | 75% | 64% | |
PaO2/FiO2 ratio > 200–300 | 16.7% | 32% | |
PaO2/FiO2 ratio 100–200 | 8.3% | 4% | 0.478 |
Day 10 PaO2/FiO2ratio; mean ± S.D. | 369.0 ± 77.7 | 388.6 ± 72.3 | 0.370 |
Hypoxemia PaO2/FiO2 ratio > 300 | 75% | 83.3% | |
PaO2/FiO2 ratio > 200–300 | 25% | 16.7% | 0.477 |
Day 5 CRP(mg/L); median (IQR) | 7.2 (5.4–17.8) | 7.8 (5.5–24.3) | 0.667 |
Normalized CRP < 10 mg/dl | 13 (54.2%) | 13 (52%) | 0.879 |
Day 10 CRP; median (IQR) | 6 (2.9–13.7) | 6 (3.4–18.0) | 0.844 |
Normalized CRP < 10 mg/dl | 16 (66.7%) | 14 (58.3%) | 0.551 |
Day 5 LDH(IU/L); mean ± S.D. | 264 ± 87.3 | 240.4 ± 95.7 | 0.368 |
Day 10 LDH; mean ± S.D. | 254.9 ± 91.8 | 237.2 ± 82.0 | 0.484 |
Day 5 SOFA score; median (IQR) | 1 (1-2.5) | 1 (1–2) | 0.883 |
Day 10 SOFA score; median (IQR) | 1 (0.5-2) | 0 (0–2) | 0.103 |
Day 5 D-dimer(mcg/mL); median (IQR) | 846.5 (470–2492) | 1021 (474–1996) | 0.976 |
Day 10 D-dimer; median (IQR) | 1043 (594.5–1712) | 1189 (576.5-3880.5) | 0.446 |
Being alive with SaO2 ≥ 96% room air | |||
Day 14 | 16 (64%) | 18 (72%) | 0.544 |
Day 28 | 21 (84%) | 21 (84%) | 1.000 |
Being alive without mechanical ventilation | |||
Day 14 | 23 (92%) | 23 (92%) | 1.000 |
Day 28 | 22 (88%) | 22 (88%) | 1.000 |
Being alive without hospitalization | |||
Day 14 | 16 (64%) | 18 (72%) | 0.544 |
Day 28 | 21 (84%) | 20 (80%) | 1.000 |
Transfer to intensive care unit | 3 (12%) | 3 (12%) | 1.000 |
Acute respiratory failure | 2 (8%) | 2 (8%) | 1.000 |
Length of hospitalization (days) | |||
Excluded hospital death; median (IQR) | 13 (10–18) | 11 (9–13) | 0.227 |
Hospital mortality | 2 (8%) | 2 (8%) | 1.000 |
28-day mortality | 3 (12%) | 2 (8%) | 1.000 |
90-day mortality | 4 (16%) | 3 (12%) | 1.000 |